tiprankstipranks
Cyclo Therapeutics Inc (CYTH)
NASDAQ:CYTH
US Market

Cyclo Therapeutics (CYTH) Stock Investors

Compare
235 Followers
Based on 793,971 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CYTH
On average, investors allocate 2.53% of their portfolios to CYTH
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 793,971 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CYTH

1.4%
Last 7
Days
9.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CYTH, out of 793,971 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CYTH Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.00%
$1.24
Based on the activity of investors who made their portfolios public
The table shows changes in CYTH in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CYTH Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Nio
8.88%
-0.90%
-0.66%
8.06B
Consumer Cyclical
Lucid Group
5.40%
-0.30%
+0.61%
7.03B
Consumer Cyclical
Viking Therapeutics
3.79%
-0.67%
-2.69%
2.88B
Healthcare
Marathon Digital Holdings
4.93%
-0.55%
-0.12%
4.31B
Financial
Block
3.59%
-0.12%
+3.88%
34.28B
Technology
Ford Motor
5.70%
-0.80%
-0.06%
38.52B
Consumer Cyclical
Riot Platforms
4.52%
-1.02%
-1.44%
2.60B
Financial
CVS Health
4.38%
-0.86%
-1.31%
84.65B
Healthcare
Trade Desk
3.35%
+0.69%
+10.58%
27.15B
Technology
Target
3.72%
-0.44%
+3.66%
47.22B
Consumer Defensive
Based on the activity of 793,971 active portfolios
Open your Smart Portfolio

CYTH Investor Analysis

CYTH investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.9%
of CYTH holders
are under 35
Average Segment Performance
Average P/E Ratio17.86
Beta11.00
Dividend Yield3.91%
CYTH investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
50.0%
of CYTH holders
are between 35–55
Average Segment Performance
Average P/E Ratio16.98
Beta19.48
Dividend Yield3.42%
CYTH investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
34.1%
of CYTH holders
are over 55
Average Segment Performance
Average P/E Ratio13.92
Beta12.14
Dividend Yield3.66%
Overview of age group and performance of CYTH stock investors
See who invests in CYTH according to age group and performance.

FAQ

How many retail Investors hold CYTH?
<0.1% of TipRanks' retail investors hold CYTH in their portfolios.
    What is CYTH Investor Sentiment?
    CYTH’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CYTH in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of CYTH in the last 7 days.
        What percentage of retail investors changed their holding of CYTH in the last 30 days?
        ▼ 9.2% of TipRanks' retail investors changed their holding of CYTH in the last 30 days.
          What is the average age of retail investors who hold CYTH?
          The average age of CYTH Holders is between 35–55.
            What other stocks have CYTH investors also bought?
            CYTH Investors also bought NIO, LCID, VKTX, MARA, XYZ, F, RIOT, CVS, TTD, TGT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              ALKSAlkermes
              ALNYAlnylam Pharma
              CORCencora
              AZNAstraZeneca
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis